Position in HLN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,245,629
+$126,361 QoQ
Shares Held
133,508
+19.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#129
of 639 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 4%
Shared 0%
None 96%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NewEdge Advisors, LLC holds $12,323,215 across 27 Drug Manufacturers - Specialty & Generic names. HLN ranks #5 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
36,078 | $2,592,565 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
12,619 | $2,126,806 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
3,861 | $2,092,005 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
37,994 | $1,287,236 | |
| 5 | HLN |
Haleon plc
This page
|
133,508 | $1,245,629 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
21,721 | $753,067 | |
| 7 | VTRS |
Viatris Inc
|
39,976 | $634,818 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
16,739 | $605,951 |
All Filings in HLN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,245,629 | 133,508 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,119,268 | 111,815 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $1,267,884 | 125,409 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $584,619 | 65,175 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $669,020 | 64,515 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $596,840 | 58,002 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $581,453 | 60,949 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $357,455 | 33,786 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $217,238 | 26,300 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $175,929 | 20,722 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $218,095 | 26,500 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $164,909 | 19,797 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $128,834 | 15,374 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $61,513 | 7,557 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $128,536 | 16,067 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||